Publication Procedure Sample Clauses

Publication Procedure. ‌ The default arrangement is “assumed permission”. If the publishing party does not receive a written objection from the reviewing party within [45]/[60]/[90] days of submission of notification of publication then permission to publish will be deemed to have been given. The ZonMw Terms and Conditions Governing Grants of ZonMw allows for a maximum period of 90 days. 1. A Party wishing to publish in written form, oral presentation or make public in any other form, information relating to the Background, Results or any other information regarding the Project – confidential or not– will submit in writing to the Project Leader the intended publication 45 days before the intended publication date or before the date of submission for disclosure to review the publication. 2. The intended publication will clearly state the intended publication date. 3. The Project Leader will promptly make the intended publication available to the other Parties. 4. The intended publication is Confidential Information and as such protected in the manner this agreement provides for. 5. The Parties will have 45 days to review the intended publication. 6. The Parties can, by giving written Notice to the Project Leader, raise an objection with regard to the inclusion of their Confidential Information or may request a delay for a maximum of 90 days after receipt of the written Notice by the Project Leader, in order to seek patent or similar protection for the Results that are proposed to be published. 7. The publishing party will remove any Confidential Information. Any other comments will be considered by the author(s) in good faith. The author is under no obligation to incorporate such comments.

Publication Procedure. At the end of the research, the publishable part of the Results will be described in the final report as defined under section 4.4.3. Review of publications Any publication or communication, whether written or oral, in connection with Result is required to be submitted to the Collaborative Board. To this end, the full text of the proposed publication or communication shall be submitted to the Collaborative Board. If the Collaborative Research Project has established a secure web site, then the full text can be submitted through it. Each member of the Collaborative Board will have the possibility to appoint one or several internal expert(s) to assess the content of the publication. Each member of the Collaborative Board will have one (1) calendar month from the date of submission of the publication to object to it in writing to the Chair. Beyond this period, if no objection has been received consent shall be deemed to have been given. This obligation, nonetheless, should not prevent the application of a Patent in accordance with the provisions of this Consortium Agreement, nor should it unnecessarily prevent a possible commercial use.

Publication Procedure. Institution agrees to submit any proposed disclosure, publication or presentation to Sponsor for review at least sixty (60) days prior to submitting any such proposed publication to a publisher or proceeding with such proposed presentation/disclosure. Within thirty (30) days of its receipt, Sponsor shall advise Institution in writing of any information contained therein which is Confidential Information (other than Study Data) or which may impair the availability of patent protection for Inventions. Sponsor shall have the right to require Institution as applicable, to remove specifically identified Confidential Information (other than Study Data) and/or to delay the proposed publication or presentation for an additional one hundred and fifty (150) days to enable Sponsor to seek patent protection for Inventions. Nothing in this Section 5.3 shall be construed as enabling or authorizing Institution to disclose Confidential Information without Sponsor’s prior written consent in each case, even if such information was furnished to Institution by or on behalf of Sponsor in connection with the Study. If the Parties disagree concerning the accuracy and appropriateness of the data analysis and presentation, or whether certain information is part of Sponsor’s “Confidential Information”, the Parties shall meet and discuss the matter in good faith to attempt to amicably resolve the dispute. 5.4Media Contacts Institution shall not, and shall ensure that Institution’s Study Staff do not engage in interviews or other contacts with the media, including but not limited to newspapers, radio, television and the Internet, related to the Study, the Investigational Product, Inventions, or Study Data without the prior jakékoli třetí straně či nezveřejní jakákoli Studijní data či údaje jakékoli třetí straně, a to v rozsahu větším, nežli v jakém mohou být odhaleny, zveřejněny, zpřístupněny či sděleny v jakékoli publikaci, prezentaci či jiném odhalení na základě odstavce 5.

Publication Procedure. On completion of the

Publication Procedure. Postup při publikování

Publication Procedure. The Participant shall be entitled to publish the Results, however with due observance of the following publication procedure: The Project Leader will submit an intended publication to NWO at least 30 days before its intended disclosure. NWO will then submit the publication to the User Committee and ask them to let NWO know within 10 working days whether they consider that the publication contains a patentable invention and/or it has Utilisation possibilities. NWO will let the Project Leader know within 30 days after the publication has been submitted to NWO whether there is any objection to its publication. If no objection has been made within this period, the Project Leader may disclose the publication. NWO may decide to suspend the publication for up to 9 months if there is an objection or in order to obtain patent protection for Results contained in the publication. NWO will decide on this after consulting the Project Leader.

Publication Procedure. Institution agrees to submit any proposed disclosure, publication or presentation to Sponsor for review at least sixty (60) days prior to submitting any such proposed publication to a publisher or proceeding with such proposed presentation/disclosure. Within thirty (30) days of its receipt, Sponsor shall advise Institution in writing of any information contained therein which is Confidential Information (other than Study Data) or which may impair the availability of patent protection for Inventions. Sponsor shall have the right to require Institution as applicable, to remove specifically identified Confidential Information (other than Study Data) and/or to delay the proposed publication or presentation for an additional one hundred and fifty (150) days to enable Sponsor to seek patent protection for Inventions. Nothing in this Section 5.3 shall be construed as enabling or authorizing Institution to předčasnému ukončení Studie, Poskytovatel zdravotních služeb bude oprávněn publikovat a prezentovat výsledky činnosti Poskytovatele zdravotních služeb, jež je prováděna na základě této Smlouvy, a to včetně Studijních dat a údajů, výhradně v souladu s podmínkami stanovenými v odstavci 5.3 „Postup při publikování“.

Publication Procedure to ensure that the 4.4.2 Publication of another Party’s Foreground or Background For the avoidance of doubt, no Party shall have the right to publish or allow the publishing of any data which includes Foreground, Background or Confidential Information of any other Party, even where such data is amalgamated with the Party’s Foreground, Background or other information, document or material without the other Party’s prior written approval. 4.1 is not considered as an approval. Where publications relate to jointly-developed results, each Party involved must give its consent to publish and such consent not to be unreasonably delayed.

Publication Procedure. On completion of the Trial and evaluation of the results, or abandonment of the Trial, respectively, the Institution or the Principal Investigator may publish or otherwise publicly disclose the results of the Trial or the treatment of any Subject participating in the Trial for internal research and educational purposes, subject, however, to the following conditions and compliance with Section 7(c) above. The same rules applies whenever the Principal Investigator wishes to make a presentation on all or part of the Trial related information. A copy of such disclosure shall be given to Hexal for review, with reference to this paragraph, at least ninety (90) business days prior to delivery to any other party. Hexal has the right to require amendments to any such proposed 8.